Napieralski, R.

cancer patient plasminogen activator breast methylation tumor inhibitor urokinase-type plasminogen activator biomarker level tissue pai ‑1 breast cancer study prognostic expression marker carcinoma prostate urokinase-type therapy prostate cancer methylated promoter survival disease protein plasminogen activator inhibitor methylated genes metastasi urokinase pai ‑1 levels cell carcinoma hypermethylation outcome trial tumour receptor treatment system detection speci urokinase plasminogen activator cancer patients stage cancer res colorectal upa levels value status breast cancer patients review lung cancer pai ‑1 expression utility analysis . cancer malignancy prognosis invasion cancer biomarkers rassf factor phase screening glioma association . oncol dna methylation cancer biomarker anticancer res schmitt oncol dna methylation markers european serum plasminogen activation system speci ficity island